Extrusion's role in pharmaceutical manufacturing
Hot-melt extrusion is an established industrial technology, used since the 1930s. It is a relatively new but viable technique for developing complex drug delivery systems in the pharmaceutical industry. The process is inert, preventing potential drug degradation caused by hydrolysis. This characteristic makes it suitable for materials with poor compaction properties and for handling sensitive active pharmaceutical ingredients (APIs).
The pelletizing challenge for sticky polymers
In general polymer processing, an underwater pelletizing system involves melting the polymer, squeezing it into a water-filled Cutting Chamber, then pelletizing, conveying, and dewatering. For sticky polymers, this system produces superior spherical pellets and is versatile. However, water-cooled systems are not suitable in the pharmaceutical field. Industry research notes this is due to water solubility of the API and high purity requirements.
Adapting pelletizing technology for pharma
This creates a specific need for equipment compatible with pharmaceutical hot-melt extrusion. Some systems are designed as melt pelletizers for manufacturing pharmaceutical spherical particles in these processes. Without water to cool and lubricate the cut, the mechanical demands on the cutting components increase significantly. The cutting action happens directly on the die face as the molten formulation emerges.
Material selection for cutter performance
The Cutter Blades must withstand continuous abrasion from the polymer matrix, which often contains hard excipients, while maintaining a sharp edge for clean cuts. Tungsten carbide tipped blades are a common material choice for this application due to their hardness and wear resistance. These blades are used in systems like GALA pelletizers, which are employed in pharmaceutical extrusion lines. Their performance directly influences pellet shape, consistency, and production uptime. We supply these components for the industry's continuous manufacturing lines.